A detailed history of Srs Capital Advisors, Inc. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 4 shares of IDXX stock, worth $1,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 2 100.0%
Holding current value
$1,911
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$515.08 - $576.87 $1,030 - $1,153
2 Added 100.0%
4 $2,000
Q4 2023

Feb 06, 2024

BUY
$391.37 - $557.56 $782 - $1,115
2 New
2 $1,000
Q2 2023

Aug 14, 2023

SELL
$450.7 - $503.61 $111,322 - $124,391
-247 Reduced 99.6%
1 $0
Q1 2023

May 16, 2023

SELL
$406.01 - $514.59 $54,405 - $68,955
-134 Reduced 35.08%
248 $124,000
Q4 2022

Feb 24, 2023

SELL
$324.64 - $441.27 $13,310 - $18,092
-41 Reduced 9.69%
382 $155,000
Q3 2022

Nov 03, 2022

SELL
$325.8 - $407.78 $3,258 - $4,077
-10 Reduced 2.31%
423 $138,000
Q2 2022

Aug 22, 2022

BUY
$327.37 - $553.44 $24,880 - $42,061
76 Added 21.29%
433 $152,000
Q1 2022

May 12, 2022

BUY
$466.52 - $631.01 $7,464 - $10,096
16 Added 4.69%
357 $195,000
Q3 2021

Nov 05, 2021

SELL
$621.9 - $705.76 $25,497 - $28,936
-41 Reduced 10.73%
341 $212,000
Q2 2021

Aug 02, 2021

BUY
$486.36 - $637.08 $11,186 - $14,652
23 Added 6.41%
382 $241,000
Q4 2020

Feb 03, 2021

BUY
$383.85 - $499.87 $1,535 - $1,999
4 Added 1.13%
359 $179,000
Q3 2020

Nov 12, 2020

BUY
$334.54 - $406.31 $33,119 - $40,224
99 Added 38.67%
355 $140,000
Q2 2020

Aug 06, 2020

BUY
$230.66 - $330.16 $56,281 - $80,559
244 Added 2033.33%
256 $85,000
Q1 2020

May 13, 2020

BUY
$182.94 - $290.97 $2,195 - $3,491
12 New
12 $3,000

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $39.8B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.